Back to results
US 2021/0260089 A1Published application
Use of mannuronic diacid composition in treatment of parkinson's disease
AssigneesShanghai Green Valley Pharmaceutical Co., Ltd., Shanghai Institute of Materia Medica, Chinese Academy of Sciences
InventorsMeiyu Geng, Xianliang Xin, Xiaoguang Du, Zhenqing Zhang, Jian Ding
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of Parkinson's disease.
Claims19
A method of treating a patient suffering from Parkinson's disease;
- comprising administering to the patient an effective amount of the mannuronic diacid oligosaccharide composition, wherein the mannuronic diacid oligosaccharide composition comprises mannuronic diacids having Formula (III) or a pharmaceutically acceptable salt thereof:
- wherein n is an integer selected from 1 to 9, m is selected from 0, 1 or 2, m′ is selected from 0 or 1, and
- wherein,
- the total weight of mannuronic diacids wherein n=1-5 accounts for no less than 60% of the total weight of the composition;
- the total weight of mannuronic diacids wherein n=1-2 accounts for less than 60% of the total weight of the composition.
2 more elements
(canceled)
Dependencies are inferred from the claim text.